Potential for efficacy of the oncolytic herpes simplex virus 1716 in patients with oral squamous cell carcinoma Journal Article


Authors: Mace, A. T. M.; Ganly, I.; Soutar, D. S.; Brown, S. M.
Article Title: Potential for efficacy of the oncolytic herpes simplex virus 1716 in patients with oral squamous cell carcinoma
Abstract: Background. Herpes simplex virus (HSV) 1716 is a selectively replicating oncolytic virus. Our objective was to assess the potential efficacy of HSV1716 in patients with oral squamous ceil carcinoma (SCC) by intratumoral injection. Methods. Twenty patients with oral SCC had a single intratumoral injection of HSV1716 at a dose of 105 pfu (plaque forming unit) or 5 × 105 pfu. Injections were done at 1, 3, or 14 days before surgical resection. The tumors were assessed for evidence of viral replication and necrosis. Immunologic response to virus and toxicity was also assessed. Results. Intratumoral injections were well tolerated with no adverse effects. Evidence of biological activity was lacking, with no increase in detectable virus in tumor samples. Conclusion. Intratumoral injection of HSV1716 is safe but with little evidence for viral replication or efficacy. Further studies at higher doses are required to determine the potential efficacy of this virus in head and neck cancer. ©2008 Wiley Periodicals, Inc.
Keywords: adult; clinical article; human tissue; aged; middle aged; cancer surgery; unclassified drug; clinical trial; drug tolerability; squamous cell carcinoma; carcinoma, squamous cell; drug efficacy; drug safety; side effect; cancer patient; polymerase chain reaction; fever; immune response; biological activity; head and neck cancer; oncolytic virus; oncolytic virotherapy; dna, viral; herpesvirus 1, human; virus replication; absence of side effects; herpes simplex virus; mouth carcinoma; mouth neoplasms; tachycardia; viral therapy; tumor necrosis; hsv1716; oral ssc; oncolytic herpes simplex virus 1716; blood pressure fluctuation; injections, intralesional
Journal Title: Head & Neck
Volume: 30
Issue: 8
ISSN: 1043-3074
Publisher: John Wiley & Sons, Inc.  
Date Published: 2008-08-01
Start Page: 1045
End Page: 1051
Language: English
DOI: 10.1002/hed.20840
PUBMED: 18615711
PROVIDER: scopus
DOI/URL:
Notes: --- - "Cited By (since 1996): 14" - "Export Date: 17 November 2011" - "CODEN: HEANE" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ian Ganly
    432 Ganly